Evidence map›Paper›PMID 37365779›Full record

ArticleThe American journal of case reports2023

Challenges in Management of Concomitant Primary Aldosteronism and Pheochromocytoma.

David Veríssimo, Joana Vinhais, Catarina Rodrigues Ivo, Isabel Sousa, Ana Cláudia Martins, João Nunes E Silva, Luís Lopes, Dolores Passos, João Jácome de Castro, Mafalda Marcelino

Open access · hybridAbstract readCase Reports
In one paragraph

Article in The American journal of case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

David VeríssimoEndocrinology Service, Armed Forces Hospital, Lisboa, Portugal.
Joana VinhaisEndocrinology Service, Armed Forces Hospital, Lisboa, Portugal.
Catarina Rodrigues IvoEndocrinology Service, Armed Forces Hospital, Lisboa, Portugal.
Isabel SousaImaging Service, Armed Forces Hospital, Lisboa, Portugal.
Ana Cláudia MartinsEndocrinology Service, Armed Forces Hospital, Lisboa, Portugal.
João Nunes E SilvaEndocrinology Service, Armed Forces Hospital, Lisboa, Portugal.
Luís LopesEndocrinology Service, Armed Forces Hospital, Lisboa, Portugal.
Dolores PassosEndocrinology Service, Armed Forces Hospital, Lisboa, Portugal.
João Jácome de CastroEndocrinology Service, Armed Forces Hospital, Lisboa, Portugal.
Mafalda MarcelinoEndocrinology Service, Armed Forces Hospital, Lisboa, Portugal.
Armed Forces Hospital · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Primary aldosteronism and pheochromocytoma are endocrine causes of secondary arterial hypertension. The association of primary aldosteronism and pheochromocytoma is rare and the involved mechanisms are poorly understood. Either there is a coexistence of both diseases or the pheochromocytoma stimulates the production of aldosterone. Since management approaches may differ significantly, it is important to properly diagnose the 2 conditions. We describe concomitant pheochromocytoma and primary aldosteronism in a patient with resistant hypertension, which demanded a challenging and individualized approach. CASE REPORT A 64-year-old man was sent for observation in our department for type 2 diabetes and resistant hypertension. Laboratory work-up suggested a primary aldosteronism and a pheochromocytoma. The abdominal CT (before and after intravenous contrast, with portal and delayed phase acquisitions) revealed an indeterminate right adrenal lesion and 3 nodules in the left adrenal gland: 1 indeterminate and 2 compatible with adenomas. A 18F-FDOPA PET-CT showed increased uptake in the right adrenal gland. The patient underwent a right adrenalectomy and a pheochromocytoma was confirmed. An improvement in glycemic control was observed after surgery but the patient remained hypertensive. A captopril test confirmed the persistence of primary aldosteronism, and he was started on eplerenone, achieving blood pressure control. CONCLUSIONS This case highlights the challenges in diagnosing and treating the simultaneous occurrence of pheochromocytoma and primary aldosteronism. Our main goal was surgical removal of the pheochromocytoma due to the risk of an adrenergic crisis.

Indexed as

Adrenal Gland NeoplasmsDiabetes Mellitus, Type 2HyperaldosteronismHypertensionPheochromocytomaAdrenalectomyHumansMaleMiddle AgedPositron Emission Tomography Computed Tomography

Identifiers

PMID37365779
PMCPMC10311573
OpenAlexW4379383466

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.